According to Hikma Pharmaceuticals 's latest financial reports the company's total liabilities are C$3.85 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | C$3.27 B | 3.97% |
2022-12-31 | C$3.15 B | 29.84% |
2021-12-31 | C$2.42 B | -4.17% |
2020-12-31 | C$2.53 B | 7.71% |
2019-12-31 | C$2.35 B | -4.07% |
2018-12-31 | C$2.45 B | 4.85% |
2017-12-31 | C$2.33 B | -10.85% |
2016-12-31 | C$2.62 B | 51.89% |
2015-12-31 | C$1.72 B | 43.79% |
2014-12-31 | C$1.20 B | 26.07% |
2013-12-31 | C$0.95 B | 8.63% |
2012-12-31 | C$0.87 B | 10.97% |
2011-12-31 | C$0.79 B | 126.22% |
2010-12-31 | C$0.34 B | -2.19% |
2009-12-31 | C$0.35 B | -17.82% |
2008-12-31 | C$0.43 B | -7.18% |
2007-12-31 | C$0.46 B | 190.27% |
2006-12-31 | C$0.16 B | 25.42% |
2005-12-31 | C$0.12 B | 5.71% |
2004-12-31 | C$0.12 B | 63.44% |
2003-12-31 | C$74.44 M | 0.64% |
2002-12-31 | C$73.97 M |